Shuttle Pharmaceuticals Holdings (SHPH) Short-term Investments (2023 - 2024)
Shuttle Pharmaceuticals Holdings (SHPH) recorded quarterly Short-term Investments of $1.6 million in Q2 2024, down 42.64% quarter-over-quarter from $2.8 million in Q1 2024, and down 44.91% on a YoY basis from $2.9 million in Q3 2023.
Shuttle Pharmaceuticals Holdings (SHPH) Short-term Investments (2023 - 2024) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Short-term Investments history runs 2 years deep, the most recent figure standing at $1.6 million for Q2 2024.
- In Q2 2024, Short-term Investments fell 44.91% year-over-year to $1.6 million; the TTM figure through Jun 2024 stood at $1.6 million (down 44.91% YoY), while the FY2023 annual figure was $2.9 million, changed N/A from the prior year.
- Short-term Investments was $1.6 million for Q2 2024 at Shuttle Pharmaceuticals Holdings, down from $2.8 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $3.0 million in Q1 2023 to a low of $1.6 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn |
| 10 | Shuttle Pharmaceuticals Holdings | 19.62 Mn | 18.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 1.60 Mn |
| Mar 31, 2024 | 2.79 Mn |
| Dec 31, 2023 | 2.89 Mn |
| Sep 30, 2023 | 2.92 Mn |
| Jun 30, 2023 | 2.90 Mn |
| Mar 31, 2023 | 2.99 Mn |